In this episode of ATTD 2025 Conference Catch-Up, we dive into Continuous Glucose Monitoring (CGM) in Type 2 Diabetes, featuring discussions on the impact of CGM on glycemic control, cost-effectiveness, and its integration with lifestyle interventions and medications for improved diabetes management. Join us as we summarize key takeaways from these thought-provoking presentations: Real World Data on CGM in Type 2 Diabetes - Glucose Control Improvement – Dr. Richard Bergenstal Glycemic Excursion Minimization (GEM): A Lifestyle Intervention for the Management of Type 2 Diabetes – Prof. Chiara Fabris Cost Benefits of CGM Use in Type 2 Diabetes – Dr. Roy Beck CGM-Based Intensification and De-Intensification of Therapy in Type 2 Diabetes – Prof. Irl Hirsch This episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals focused on Type 2 diabetes management, looking to learn more about the role of CGM in optimizing treatment plans, improving glycemic control, and managing healthcare costs. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related